Catalyst Event
Medtronic PLC (MDT) · Other
From Akros SCHK HK-Global Musk Index (ASHGMUSK)
4/29/2026, 12:00:00 AM
Medtronic received U.S. Food and Drug Administration (FDA) approval for the Mosaic Neo mitral valve, its next-generation mitral bioprosthesis, on April 29, 2026.
Korean Translation
메드트로닉은 2026년 4월 29일 차세대 승모판막 생체 인공판막인 Mosaic Neo 승모판막에 대해 미국 식품의약국(FDA)의 승인을 받았음.
Related Recent Events
Geely Automobile Holdings Ltd (175) · Other
A final dividend of HK$0.50 per share for FY2025 has an ex-dividend date of June 12, 2026, scheduled. This 52% dividend increase is estimated to have a 5% or more price impact.
6/12/2026, 12:00:00 AM
China Mobile Ltd (941) · Other
Final dividend of HK$2.52 per share for the year ended December 31, 2025, with an ex-dividend date of June 5, 2026, and payment on June 24, 2026, scheduled.
6/5/2026, 12:00:00 AM
China Unicom (Hong Kong) Ltd (762) · Other
Final dividend for fiscal year 2025 of RMB 0.1329 per share. The ex-dividend date is June 3, 2026, with payment on June 24, 2026, scheduled. Medium importance is estimated based on the dividend payout.
6/3/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic is scheduled to report its financial results for the fourth quarter and full fiscal year 2026 on June 3, 2026. This event is expected to have a medium impact as earnings reports typically drive significant price volatility scheduled.
6/3/2026, 12:00:00 AM
China Telecom Corp Ltd (728) · Other
Ex-dividend date (2026-06-02) for the final dividend of RMB 0.0908 per share for the fiscal year 2025. Low importance is estimated as it is a standard dividend procedure, scheduled.
6/2/2026, 12:00:00 AM
Fanuc Corp (6954) · Other
Cancellation of 111,063 treasury shares scheduled for May 29, 2026, scheduled. This minor reduction in supply is estimated to have a ≥1% price impact.
5/29/2026, 12:00:00 AM